Another study in migraine patients reproduced the induction of migraine-like attacks in 72% of patients and showed that PACAP induced premonitory symptoms in 48% of patients compared to 9% after CGRP [117], suggesting an effect on central PAC1 receptors. Here, ADCYAP1 is linked to migraine disorder.